Therapeutic compounds

Details for Australian Patent Application No. 2009223435 (hide)

Owner Allergan, Inc.

Inventors Dinh, Danny T.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009223435

PCT Pub. Number WO2009/114307

Priority 61/034,866 07.03.08 US; 12/394,647 27.02.09 US

Filing date 2 March 2009

Wipo publication date 17 September 2009

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/24 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

30 September 2010 PCT application entered the National Phase

  PCT publication WO2009/114307 Priority application(s): WO2009/114307

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223437-Apparatus for optimizing a chemical looping combustion plant using a model predictive controller

2009223412-Solar energy production system